• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26920
Device Problem Material Deformation (2976)
Patient Problems No Consequences Or Impact To Patient (2199); Patient Problem/Medical Problem (2688)
Event Date 04/17/2019
Event Type  Injury  
Manufacturer Narrative
Age at time of event: 18 years or older.
 
Event Description
It was reported that the stent foreshortened which required a second stent to be placed.A 6x80x75 innova was selected for a patient procedure to recanalize the 100% occluded superficial femoral artery.The lesion had a normal amount of tortuosity and was 5% calcified.The length of the lesion was measured to be around 6-7 cm long.The innova was selected and the inner pouch confirmed that the label showed 6x80x75.The stent was then deployed without any issues.Post deployment, the implantable length was measured to be 60 cm.Due to the stent shortening, a second stent was deployed to cover the intended length of the lesion.The patient's condition following procedure was fine.A week after the procedure, occlusion occurred on the proximal portion of the vessel; right above the area where the stents were implanted.The patient's latest reported condition was okay.No further complications were reported.
 
Event Description
It was reported that the stent foreshortened which required a second stent to be placed.A 6x80x75 innova was selected for a patient procedure to recanalize the 100% occluded superficial femoral artery.The lesion had a normal amount of tortuosity and was 5% calcified.The issues.Post deployment, the implantable length was measured to be 60 cm.Due to the stent shortening, a second stent was deployed to cover the intended length of the lesion.The patient's condition following procedure was fine.A week after the procedure, occlusion occurred on the proximal portion of the vessel; right above the area where the stents were implanted.The patient's latest reported condition was okay.No further complications were reported.
 
Manufacturer Narrative
Age at time of event: 18 years or older.Correction: patient codes: changed from 2199 to 2688.Device evaluated by mfr: returned product consisted of an innova self-expanding stent system.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.The customer provided photos.In the second photo a measurement of 57.71mm was taken which appears to be for the implanted stent.Visual examination revealed a kink at the nosecone.Microscopic examination revealed no additional damages.The stent was deployed and implanted so it did not return for product analysis.There is blood present on and in the device.Inspection of the remainder of the device presented no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8600233
MDR Text Key144718594
Report Number2134265-2019-04869
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/11/2022
Device Model Number26920
Device Catalogue Number26920
Device Lot Number0023332762
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/17/2019
Initial Date Manufacturer Received 04/18/2019
Initial Date FDA Received05/10/2019
Supplement Dates Manufacturer Received06/14/2019
Supplement Dates FDA Received07/01/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-